NASDAQ · Analyst Forecast

Twist Bioscience Corporation (TWST) Stock Forecast & Price Target

$112.00 NASDAQ: TWST Market Cap $7.37B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Twist Bioscience Corporation (TWST), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Twist Bioscience Corporation, analysts forecast revenue rising from $456.36M in 2026 to $1.28B in 2031; the average estimate for 2031 earnings per share is $2.23; with published estimates ranging from $2.17 to $2.36; 9 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$112.00
Consensus targetThe average of the price targets analysts have published.$144.91
Median targetThe middle target, less affected by a single outlier.$137.00
Highest targetThe most optimistic published target.$215.00
Lowest targetThe most pessimistic published target.$89.00
Difference from priceHow far the consensus target sits from today’s price.+29.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2026$456.11M$456.36M$456.44M9
2027$549.68M$555.47M$564.17M8
2028$643.24M$657.42M$685.07M7
2029$729.09M$774.50M$869.40M4
2030$990.92M$1.01B$1.06B2
2031$1.26B$1.28B$1.34B1

Earnings per share forecast

YearLowAverageHighAnalysts
2026−$2.16−$2.15−$2.149
2027−$1.41−$1.38−$1.348
2028−$1.01−$0.96−$0.937
2029−$0.65−$0.37−$0.094
2030$0.92$0.94$1.002
2031$2.17$2.23$2.361

Twist Bioscience Corporation (TWST) forecast — frequently asked questions

What is the analyst price target for Twist Bioscience Corporation?

Analysts covering Twist Bioscience Corporation (TWST) have a consensus price target of $144.91, 29.4% above the current price of $112.00. Published targets range from $89.00 to $215.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Twist Bioscience Corporation's earnings?

The average analyst estimate for Twist Bioscience Corporation (TWST) earnings per share in 2031 is 2.23, with individual estimates between 2.17 and 2.36.

How much revenue is Twist Bioscience Corporation expected to make?

Analysts forecast Twist Bioscience Corporation (TWST) revenue of $1.28B in 2031, based on 1 published estimates.

How many analysts cover TWST?

9 analysts contribute estimates for Twist Bioscience Corporation (TWST). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.